The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 28, 2017

Filed:

May. 08, 2015
Applicant:

Hanmi Pharm. Co., Ltd., Hwaseong-si, Gyeonggi-do, KR;

Inventors:

Ji Sook Kim, Yongin-si, KR;

Won Jeoung Kim, Suwon-si, KR;

Wook Jang, Seoul, KR;

Ji Young Song, Seoul, KR;

Moon Sub Lee, Cheongju-si, KR;

Nam Du Kim, Hwaseong-si, KR;

Kwee Hyun Suh, Suwon-si, KR;

Assignee:

HANMI PHARM. CO., LTD., Hwaseong-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 407/14 (2006.01); C07H 7/04 (2006.01); C07D 309/10 (2006.01); C07D 407/10 (2006.01); C07D 409/10 (2006.01); C07D 407/04 (2006.01);
U.S. Cl.
CPC ...
C07D 407/14 (2013.01); C07D 309/10 (2013.01); C07D 407/04 (2013.01); C07D 407/10 (2013.01); C07D 409/10 (2013.01); C07H 7/04 (2013.01);
Abstract

The present invention relates to a novel bicyclic derivative that has an inhibitory activity against sodium-glucose linked transporters (SGLTs) present in the intestines and kidneys, or a pharmaceutically acceptable salt, isomer, hydrate or solvate thereof, and a pharmaceutical composition including the same as an active ingredient, which effectively inhibit the SGLT activity, and thus can be used as a therapeutic agent to treat diseases caused by hyperglycemia, such as diabetes including insulin-dependent diabetes (type I diabetes mellitus) and non-insulin-dependent diabetes (type II diabetes mellitus), diabetic complications, and obesity.


Find Patent Forward Citations

Loading…